Radiopharmaceuticals company Telix Pharmaceuticals (ASX:TLX) is acquiring a pipeline of next-generation therapeutic candidates, a proprietary novel biologics technology platform, and a protein ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

We recently published a list of 13 AI News and Ratings You Probably Missed. In this article, we are going to take a look at ...

The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

Neumirna Therapeutics has raised €20m to develop microRNA therapies for epilepsy and other neurological conditions.

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

UK Biobank's proteomics study will measure 5,400 proteins in 600,000 samples, tracking changes over mid-to-late life. By ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a ...